GO:0004581 dolichyl-phosphate beta-glucosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004581 describes the enzymatic activity that transfers glucose from UDP-glucose to dolichyl phosphate, forming dolichyl beta-D-glucosyl phosphate, a key step in dolichol-linked oligosaccharide biosynthesis.
• The reaction is catalyzed by ALG5 (asparagine-linked glycosylation 5) in Saccharomyces cerevisiae and its orthologs in higher eukaryotes.
• In humans, the enzyme is localized to the endoplasmic reticulum membrane and is involved in the early steps of N-linked glycosylation.
• The lipid environment, particularly dolichyl phosphate availability, regulates the enzyme's activity and the overall flux of the dolichol cycle.
• Defects in dolichol-linked glycosylation can lead to congenital disorders of glycosylation (CDGs) and have been implicated in polycystic kidney disease and liver dysfunction.
• Studying GO:0004581 requires biochemical assays, subcellular fractionation, and CRISPR-based models to dissect its role in health and disease.
Description
Dolichyl-phosphate beta-glucosyltransferase activity (GO:0004581) is a molecular function that catalyzes the transfer of glucose from UDP-glucose to dolichyl phosphate, yielding dolichyl beta-D-glucosyl phosphate and UDP. This reaction constitutes the first glucosylation step in the assembly of the dolichol-linked oligosaccharide precursor, which is essential for N-linked protein glycosylation in the endoplasmic reticulum. The enzyme is conserved from yeast to humans and is encoded by the ALG5 gene in Saccharomyces cerevisiae. In humans, the orthologous enzyme has been biochemically characterized from liver microsomes, where it co-localizes with bile acid glucosyltransferase, suggesting additional roles in detoxification pathways. Understanding this activity is critical because proper glycosylation affects protein folding, stability, and cell signaling, and its disruption is linked to developmental and metabolic disorders.
dolichyl-phosphate beta-glucosyltransferase activity At A Glance
| GO ID | GO:0004581 |
|---|---|
| GO term | dolichyl-phosphate beta-glucosyltransferase activity |
| Ontology | molecular_function |
| Synonym | UDP-glucose:dolichyl-phosphate beta-D-glucosyltransferase activity; polyprenyl phosphate:UDP-D-glucose glucosyltransferase activity; UDP-glucose:dolichol phosphate glucosyltransferase activity |
| Major function | Catalyzes the transfer of glucose from UDP-glucose to dolichyl phosphate, forming dolichyl beta-D-glucosyl phosphate and UDP |
| Reaction | UDP-glucose + dolichyl phosphate = UDP + dolichyl beta-D-glucosyl phosphate |
| Cellular location | Endoplasmic reticulum membrane |
| Representative gene | ALG5 (Saccharomyces cerevisiae); human ortholog ALG5 |
| Pathway | N-linked glycosylation (dolichol cycle) |
What Is GO:0004581?
GO:0004581 is defined as the catalysis of the reaction: UDP-glucose + dolichyl phosphate = UDP + dolichyl beta-D-glucosyl phosphate. In other words, it is the enzyme activity that attaches a glucose molecule to dolichyl phosphate, a lipid carrier embedded in the endoplasmic reticulum membrane, using UDP-glucose as the sugar donor. This activity is synonymous with UDP-glucose:dolichyl-phosphate beta-D-glucosyltransferase and is a prerequisite for the subsequent mannosylation steps in the dolichol cycle.
Why Is dolichyl-phosphate beta-glucosyltransferase activity Important in Cell Biology?
GO:0004581 is important because it initiates the glucosylation branch of the dolichol cycle, a conserved pathway required for the biosynthesis of the lipid-linked oligosaccharide precursor (Glc3Man9GlcNAc2) that is transferred to nascent proteins in the endoplasmic reticulum. Without this activity, N-linked glycosylation is impaired, leading to protein misfolding and activation of the unfolded protein response. In humans, mutations or dysregulation of this pathway are associated with congenital disorders of glycosylation, liver disease, and polycystic kidney disease. Moreover, the enzyme's dependence on dolichyl phosphate links it to lipid metabolism and membrane homeostasis, making it a potential target for therapeutic intervention in metabolic and proliferative disorders.
• Initiates the glucosylation of dolichyl phosphate, a committed step in N-linked glycosylation.
• Essential for the synthesis of the lipid-linked oligosaccharide precursor in the endoplasmic reticulum.
• Conserved from yeast to humans, enabling genetic studies in model organisms.
• Dysregulation is linked to congenital disorders of glycosylation and liver dysfunction.
• May influence polycystic kidney disease through altered glycosylation of membrane proteins.
• The enzyme's activity is sensitive to the lipid environment, connecting glycosylation to lipid metabolism.
• Provides a potential biomarker for glycosylation-related diseases.
• Target for biochemical assays to screen for glycosylation inhibitors.
• Plays a role in bile acid glucosylation in the liver, affecting detoxification.
• Studied using subcellular fractionation to determine its precise localization.
Molecular Mechanism of dolichyl-phosphate beta-glucosyltransferase activity
Substrate Recognition and Binding
In simple terms: The enzyme grabs UDP-glucose and dolichyl phosphate and brings them together.
The enzyme binds UDP-glucose and dolichyl phosphate in a sequential manner. The hydrophilic UDP-glucose binds to the catalytic domain, while the hydrophobic dolichyl phosphate is anchored in the membrane. The enzyme's active site likely contains conserved residues that stabilize the transition state during glucose transfer. Substrate specificity studies using recombinant enzyme have shown that it prefers UDP-glucose over other nucleotide sugars and dolichyl phosphate with a specific chain length.
Catalytic Transfer of Glucose
In simple terms: The enzyme snips off glucose from UDP-glucose and attaches it to dolichyl phosphate.
The catalytic mechanism involves an inverting or retaining glycosyl transfer, where the anomeric configuration of glucose is preserved as beta-D-glucosyl phosphate. The reaction proceeds via a nucleophilic attack on the anomeric carbon of UDP-glucose, with dolichyl phosphate acting as the acceptor. Conserved aspartate or glutamate residues may act as general acid/base catalysts. The product, dolichyl beta-D-glucosyl phosphate, is then used by downstream mannosyltransferases in the dolichol cycle.
Membrane Topology and Lipid Dependence
In simple terms: The enzyme sits in the ER membrane and needs the right lipid environment to work.
The enzyme is an integral membrane protein of the endoplasmic reticulum, with its active site facing the cytoplasmic side. Its activity is modulated by the lipid composition of the membrane, particularly the concentration of dolichyl phosphate and phospholipids. Studies using rat liver microsomes have shown that the enzyme requires a fluid lipid bilayer for optimal activity, and its function is impaired in the presence of detergents that disrupt membrane integrity.
Subcellular Localization and Compartmentalization
In simple terms: The enzyme is found in specific parts of the cell, mainly the ER.
Subcellular fractionation studies in human liver have localized the enzyme to the rough and smooth endoplasmic reticulum, with some activity also detected in the nuclear envelope. It co-fractionates with other dolichol cycle enzymes, suggesting a multi-enzyme complex. In rat liver, the enzyme is enriched in the microsomal fraction, consistent with its role in the secretory pathway.
Regulation by Substrate Availability and Feedback
In simple terms: The enzyme's speed depends on how much substrate is available and may be slowed by its products.
The activity of dolichyl-phosphate beta-glucosyltransferase is primarily regulated by the availability of dolichyl phosphate, which is synthesized by the mevalonate pathway. Feedback inhibition by UDP or dolichyl beta-D-glucosyl phosphate has been proposed but not fully characterized. Additionally, the enzyme may be regulated by phosphorylation, although direct evidence is lacking. In yeast, ALG5 expression is constitutive but can be induced under conditions of ER stress.
Key Genes Involved in GO:0004581 dolichyl-phosphate beta-glucosyltransferase activity
The following genes and proteins are directly involved in or regulate dolichyl-phosphate beta-glucosyltransferase activity and the dolichol cycle.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ALG5 | Encodes the UDP-glucose:dolichyl-phosphate glucosyltransferase in Saccharomyces cerevisiae | Model for studying enzyme kinetics and glycosylation defects |
| ALG5 (human) | Ortholog of yeast ALG5, catalyzes the same reaction in humans | Linked to congenital disorders of glycosylation |
| DOLK | Dolichol kinase, phosphorylates dolichol to dolichyl phosphate | Provides substrate for GO:0004581 |
| DPM1 | Dolichyl-phosphate mannosyltransferase, uses dolichyl phosphate for mannose transfer | Competes with GO:0004581 for dolichyl phosphate |
| ALG6 | Alpha-1,3-glucosyltransferase, adds second glucose in the dolichol cycle | Downstream enzyme, mutations cause CDG-Ic |
| ALG8 | Alpha-1,3-glucosyltransferase, adds third glucose | Downstream enzyme, mutations cause CDG-Ih |
| ALG3 | Alpha-1,3-mannosyltransferase, acts after glucosylation | Dolichol cycle enzyme |
| ALG9 | Alpha-1,2-mannosyltransferase | Dolichol cycle enzyme |
| ALG12 | Alpha-1,6-mannosyltransferase | Dolichol cycle enzyme |
| RFT1 | Flipase that translocates lipid-linked oligosaccharide | Indirectly related to glucosylation |
| MPDU1 | Mannose-P-dolichol utilization defect 1 | Affects dolichol cycle |
| DDOST | Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit | Transfers oligosaccharide to protein |
| UGGT1 | UDP-glucose:glycoprotein glucosyltransferase | Quality control in ER, uses UDP-glucose |
| UGGT2 | UDP-glucose:glycoprotein glucosyltransferase 2 | ER quality control |
| PMM2 | Phosphomannomutase 2, supplies mannose for dolichol cycle | CDG-Ia |
| MPI | Mannose-6-phosphate isomerase | CDG-Ib |
| G6PC3 | Glucose-6-phosphatase, catalytic subunit 3 | Neutropenia and glycosylation defects |
| SLC35A2 | UDP-galactose transporter | Affects glycosylation |
How Is dolichyl-phosphate beta-glucosyltransferase activity Regulated?
The activity of dolichyl-phosphate beta-glucosyltransferase is regulated at multiple levels. Substrate availability, particularly the concentration of dolichyl phosphate, is a key determinant; dolichyl phosphate is synthesized by the mevalonate pathway and its levels are influenced by cholesterol biosynthesis. The enzyme's activity is also sensitive to the lipid composition of the endoplasmic reticulum membrane, with phospholipids and dolichol itself modulating its function. In yeast, ALG5 expression is constitutive, but the enzyme may be subject to feedback inhibition by its product, dolichyl beta-D-glucosyl phosphate, or by UDP. Additionally, ER stress and the unfolded protein response can indirectly affect glycosylation flux, although direct regulation of the enzyme by these pathways has not been established.
dolichyl-phosphate beta-glucosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALG5 | Congenital disorder of glycosylation (CDG) and glycosylation defects | Knockout in HEK293 cells, yeast alg5Δ |
| ALG6 | CDG-Ic | Patient fibroblasts, CRISPR knock-in of mutations |
| ALG8 | CDG-Ih | Knockout in zebrafish, mouse models |
| PKD1 | Polycystic kidney disease | Pkd1 knockout mouse, 3D cyst assays |
| UGGT1 | ER quality control and glycosylation | Overexpression in HeLa cells, KO in mouse liver |
Congenital Disorders of Glycosylation (CDGs)
Defects in the dolichol cycle, including the step catalyzed by dolichyl-phosphate beta-glucosyltransferase, can lead to CDGs. While mutations in ALG5 itself are rare, mutations in downstream enzymes such as ALG6, ALG8, and ALG12 cause CDG types I. These disorders present with developmental delay, hypotonia, and multisystem involvement. The glucosyltransferase activity is essential for the proper assembly of the lipid-linked oligosaccharide, and its impairment can exacerbate glycosylation defects.
Polycystic Kidney Disease
Polycystic kidney disease (PKD) is characterized by the growth of fluid-filled cysts in the kidneys. Abnormal glycosylation of membrane proteins, including polycystin-1 and polycystin-2, has been implicated in PKD pathogenesis. The dolichol cycle enzyme activity may influence the glycosylation status of these proteins, thereby affecting cyst formation. Although direct mutations in GO:0004581 enzyme are not a known cause of PKD, altered glycosylation pathways are observed in PKD models.
Liver Disease and Bile Acid Glucosylation
In the human liver, dolichyl-phosphate beta-glucosyltransferase co-localizes with bile acid glucosyltransferase, suggesting a role in detoxification of bile acids. This enzyme activity may contribute to the glucosylation of bile acids, making them more water-soluble for excretion. Dysregulation of this process could lead to cholestatic liver disease. Studies on human liver microsomes have shown that the enzyme is enriched in the endoplasmic reticulum, where it may participate in both N-glycosylation and bile acid metabolism.
From dolichyl-phosphate beta-glucosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the kinetic mechanism of the enzyme? | Recombinant ALG5 expressed in E. coli or insect cells, purified for enzyme assays |
| How does the enzyme localize within the ER? | Tagged knock-in of ALG5 with GFP in HeLa cells, confocal imaging |
| What are the consequences of loss of function? | CRISPR knockout of ALG5 in HEK293 or HAP1 cells, lectin blotting |
| Can point mutations alter substrate specificity? | Point mutation knock-in of catalytic residues in yeast or human cells |
| Does overexpression affect glycosylation flux? | Overexpression of ALG5 in CHO cells, glycomics analysis |
| How does the enzyme interact with other dolichol cycle enzymes? | Knock-in of split-tag (e.g., NanoBiT) into ALG5 and ALG6, interaction assays |
How to Study the dolichyl-phosphate beta-glucosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiometric enzyme assay | Glucosyltransferase activity using UDP-[3H]glucose | Kinetic studies, inhibitor screening |
| Subcellular fractionation | Localization of enzyme activity | Determining ER enrichment |
| Lectin blotting | Glycosylation status of proteins | Assessing knockout phenotypes |
| LC-MS/MS glycomics | Profile of N-linked glycans | Analyzing glycosylation defects |
| CRISPR knockout screen | Genes affecting glycosylation | Identifying modifiers |
| Fluorescence microscopy | Subcellular localization of tagged ALG5 | Live-cell imaging |
| Immunoprecipitation | Protein-protein interactions | Identifying complex partners |
Enzymatic Assays for Glucosyltransferase Activity
The activity of dolichyl-phosphate beta-glucosyltransferase can be measured using radiometric assays with UDP-[3H]glucose and dolichyl phosphate as substrates. The product, dolichyl beta-D-glucosyl phosphate, is extracted with organic solvents and quantified by scintillation counting. Alternatively, fluorescently labeled UDP-glucose can be used for real-time monitoring. These assays are typically performed with microsomal fractions or purified recombinant enzyme.
Subcellular Fractionation and Localization
To determine the subcellular localization of the enzyme, differential centrifugation and density gradient fractionation of liver or cultured cells can be employed. The enzyme activity is measured in each fraction using the radiometric assay. Immunoblotting with antibodies against ALG5 or tagged versions can confirm the localization. Studies in rat and human liver have shown enrichment in the endoplasmic reticulum.
Genetic and CRISPR Screens
CRISPR knockout screens can identify genes that modulate glycosylation, including ALG5. Libraries targeting glycosylation-related genes can be used to assess sensitivity to lectins or glycosylation inhibitors. Knockout of ALG5 leads to altered lectin binding, which can be quantified by flow cytometry or lectin blotting. These screens help uncover genetic interactions and compensatory pathways.
Glycomics and Mass Spectrometry
Changes in N-linked glycosylation due to altered glucosyltransferase activity can be analyzed by mass spectrometry of released glycans. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) can profile the lipid-linked oligosaccharide intermediates. This method is powerful for assessing the impact of mutations or drugs on the dolichol cycle.
How CRISPR Can Be Used to Study GO:0004581 dolichyl-phosphate beta-glucosyltransferase activity
Knockout
CRISPR knockout of ALG5 or other dolichol cycle genes can be achieved by introducing indels in the coding sequence. Knockout cell lines are valuable for studying the loss of glucosyltransferase activity and its effects on glycosylation, protein folding, and cell viability. These models can be validated by enzyme assays and lectin blotting.
Point Mutation
Point mutations in the catalytic residues of ALG5 can be introduced using CRISPR base editing or homology-directed repair. Such models help dissect the enzymatic mechanism and substrate specificity. For example, mutating the predicted catalytic aspartate to alanine abolishes activity, confirming its role.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) into the endogenous ALG5 locus allows for real-time imaging and immunoprecipitation of the enzyme. This approach preserves endogenous regulation and can reveal dynamic localization and interactions. Knock-in of disease-associated mutations can model glycosylation disorders.
Overexpression
Overexpression of ALG5 using CRISPR activation (CRISPRa) or lentiviral vectors can increase glucosyltransferase activity, potentially enhancing glycosylation flux. This is useful for biotechnological applications, such as improving recombinant protein production in CHO cells. Overexpression models also help study feedback regulation.
How EDITGENE Supports dolichyl-phosphate beta-glucosyltransferase activity Research
Researchers studying dolichyl-phosphate beta-glucosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in glycosylation pathways, metabolic disorders, or cancer. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for dolichyl-phosphate beta-glucosyltransferase activity research.
Frequently Asked Questions About dolichyl-phosphate beta-glucosyltransferase activity
What is dolichyl-phosphate beta-glucosyltransferase activity?
It is the enzyme activity (GO:0004581) that transfers glucose from UDP-glucose to dolichyl phosphate, forming dolichyl beta-D-glucosyl phosphate and UDP, a key step in N-linked glycosylation.
What genes are involved in dolichyl-phosphate beta-glucosyltransferase activity?
The primary gene is ALG5 in yeast and its human ortholog ALG5. Other genes in the dolichol cycle include DOLK, DPM1, ALG6, ALG8, and ALG12.
Where is dolichyl-phosphate beta-glucosyltransferase located in the cell?
It is an integral membrane protein of the endoplasmic reticulum, with its active site facing the cytoplasm.
What is the reaction catalyzed by GO:0004581?
UDP-glucose + dolichyl phosphate = UDP + dolichyl beta-D-glucosyl phosphate.
How is dolichyl-phosphate beta-glucosyltransferase activity measured?
It is typically measured using radiometric assays with UDP-[3H]glucose and dolichyl phosphate, followed by extraction and scintillation counting.
What diseases are associated with defects in this activity?
Defects in the dolichol cycle can cause congenital disorders of glycosylation, liver disease, and may contribute to polycystic kidney disease.
Can CRISPR be used to study dolichyl-phosphate beta-glucosyltransferase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be generated to study the enzyme's function and regulation.
What is the role of ALG5 in glycosylation?
ALG5 encodes the glucosyltransferase that adds the first glucose to dolichyl phosphate, initiating the glucosylation branch of the dolichol cycle.
How does the lipid environment affect the enzyme?
The enzyme requires a fluid lipid bilayer and its activity is modulated by the concentration of dolichyl phosphate and phospholipids.
What are the synonyms for GO:0004581?
Synonyms include UDP-glucose:dolichyl-phosphate beta-D-glucosyltransferase activity, polyprenyl phosphate:UDP-D-glucose glucosyltransferase activity, and UDP-glucose:dolichol phosphate glucosyltransferase activity.
Conclusion
Dolichyl-phosphate beta-glucosyltransferase activity (GO:0004581) is a fundamental enzymatic step in the dolichol cycle, essential for N-linked glycosylation and cellular homeostasis. Its study spans biochemistry, genetics, and disease modeling, with implications for congenital disorders, liver function, and kidney disease. Advances in CRISPR technology now enable precise interrogation of this activity in various cell models, promising new insights into glycosylation-related pathologies and potential therapeutic targets.
References
- 1. Adam MP et al.. 1993. Polycystic Kidney Disease, Autosomal Dominant.. PMID: 20301424
- 2. Li R et al.. 2024. [Analysis of enzyme activity and substrate specificity of dolichyl-phosphate β-glucosyltransferase].. Sheng Wu Gong Cheng Xue Bao 40(6):1833-1844 PMID: 38914494
- 3. Heesen S et al.. 1994. Isolation of the ALG5 locus encoding the UDP-glucose:dolichyl-phosphate glucosyltransferase from Saccharomyces cerevisiae.. Eur J Biochem 224(1):71-9 PMID: 8076653
- 4. Gartung C et al.. 1994. The submicrosomal localization of uridine 5'-diphosphate-glucose dolichyl-phosphate glucosyltransferase and bile acid glucosyltransferase in the human liver.. J Hepatol 20(1):32-40 PMID: 8201220
- 5. Matern H et al.. 1990. Isolation and characterization of UDP-glucose dolichyl-phosphate glucosyltransferase from human liver.. Eur J Biochem 190(1):99-105 PMID: 2163838
- 6. Rupar CA et al.. 1982. The subcellular localization of enzymes of dolichol metabolism in rat liver.. J Biol Chem 257(6):3090-4 PMID: 6277925
- 7. Schutzbach JS. 1997. The role of the lipid matrix in the biosynthesis of dolichyl-linked oligosaccharides.. Glycoconj J 14(2):175-82 PMID: 9111134
